Álvaro Pascual
About
Álvaro Pascual is a scholar working on Molecular Medicine, Pharmacology and Epidemiology.
According to data from OpenAlex, Álvaro Pascual has authored 404 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 272 papers in Molecular Medicine, 145 papers in Pharmacology and 119 papers in Epidemiology. Recurrent topics in Álvaro Pascual's work include Antibiotic Resistance in Bacteria (272 papers), Antibiotics Pharmacokinetics and Efficacy (143 papers) and Bacterial Identification and Susceptibility Testing (68 papers). Álvaro Pascual is often cited by papers focused on Antibiotic Resistance in Bacteria (272 papers), Antibiotics Pharmacokinetics and Efficacy (143 papers) and Bacterial Identification and Susceptibility Testing (68 papers). Álvaro Pascual collaborates with scholars based in Spain, United States and Australia. Álvaro Pascual's co-authors include Luis Martínez‐Martínez, Jesús Rodríguez‐Baño, Evelio J. Perea, George A. Jacoby, José Manuel Rodríguez-Martínez, M.D. Navarro, Isabel Garcı́a, Lorena López‐Cerero, Belén Gutiérrez‐Gutiérrez and Miguel A. Muniain and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and PLoS ONE.
In The Last Decade
Álvaro Pascual
397 papers receiving 13.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Álvaro Pascual Spain | 59 | 10.3k | 4.2k | 4.0k | 3.7k | 2.6k | 404 | 14.3k | ||
| Luis Martínez‐Martínez Spain | 57 | 8.7k 0.8× | 2.6k 0.6× | 3.9k 1.0× | 2.8k 0.8× | 2.8k 1.1× | 330 | 12.0k | ||
| Alkiviadis Vatopoulos Greece | 31 | 8.6k 0.8× | 2.8k 0.7× | 3.3k 0.8× | 1.9k 0.5× | 2.7k 1.0× | 77 | 13.0k | ||
| Patricia A. Bradford United States | 52 | 9.0k 0.9× | 1.9k 0.5× | 3.0k 0.7× | 3.4k 0.9× | 2.6k 1.0× | 122 | 11.6k | ||
| Jesús Rodríguez‐Baño Spain | 62 | 8.5k 0.8× | 5.3k 1.3× | 3.3k 0.8× | 2.7k 0.7× | 1.7k 0.6× | 356 | 14.4k | ||
| Johann Pitout Canada | 67 | 14.4k 1.4× | 4.2k 1.0× | 7.8k 2.0× | 2.6k 0.7× | 2.7k 1.0× | 201 | 17.1k | ||
| Daniel F. Sahm United States | 66 | 7.7k 0.7× | 4.4k 1.1× | 2.0k 0.5× | 4.6k 1.3× | 1.9k 0.7× | 270 | 13.5k | ||
| Ana Cristina Gales Brazil | 51 | 7.0k 0.7× | 2.1k 0.5× | 2.9k 0.7× | 2.2k 0.6× | 2.4k 0.9× | 272 | 9.8k | ||
| B Olsson-Liljequist Sweden | 28 | 7.0k 0.7× | 3.1k 0.7× | 2.5k 0.6× | 1.6k 0.4× | 2.4k 0.9× | 77 | 12.0k | ||
| Germán Bou Spain | 56 | 7.6k 0.7× | 2.5k 0.6× | 3.4k 0.9× | 2.1k 0.6× | 3.8k 1.5× | 317 | 11.8k | ||
| Anna-Pelagia Magiorakos Sweden | 10 | 6.9k 0.7× | 2.5k 0.6× | 2.4k 0.6× | 1.5k 0.4× | 2.2k 0.8× | 12 | 11.2k |
Countries citing papers authored by Álvaro Pascual
Since
Specialization
Citations
This map shows the geographic impact of Álvaro Pascual's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Álvaro Pascual with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Álvaro Pascual more than expected).
Fields of papers citing papers by Álvaro Pascual
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Álvaro Pascual. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Álvaro Pascual. The network helps show where Álvaro Pascual may publish in the future.
Co-authorship network of co-authors of Álvaro Pascual
This figure shows the co-authorship network connecting the top 25 collaborators of Álvaro Pascual. A scholar is included among the top collaborators of Álvaro Pascual based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Álvaro Pascual. Álvaro Pascual is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Delgado-Valverde, Mercedes, et al.. (2023). Activity of imipenem/relebactam and comparators against KPC-producing Klebsiella pneumoniae and imipenem-resistant Pseudomonas aeruginosa. European Journal of Clinical Microbiology & Infectious Diseases. 43(3). 445–457.
2.
Gual-de-Torrella, Ana, Mercedes Delgado-Valverde, Patricia Pérez‐Palacios, et al.. (2022). Prevalence of the fimbrial operon mrkABCD, mrkA expression, biofilm formation and effect of biocides on biofilm formation in carbapenemase-producing Klebsiella pneumoniae isolates belonging or not belonging to high-risk clones. International Journal of Antimicrobial Agents. 60(4). 106663–106663.
3.
Machuca, Jesús, Rafael López-Rojas, Felipe Fernández-Cuenca, & Álvaro Pascual. (2019). Comparative activity of a polyhexanide–betaine solution against biofilms produced by multidrug-resistant bacteria belonging to high-risk clones. Journal of Hospital Infection. 103(1). e92–e96.
4.
Blasco, Lucía, Antón Ambroa, María López, et al.. (2019). Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii. Microorganisms. 7(11). 556–556.
5.
López‐Cerero, Lorena, et al.. (2018). Prevalence of ST131 Clone Producing Both ESBL CTX-M-15 and AAC(6′)Ib-cr Among Ciprofloxacin-Resistant Escherichia coli Isolates from Yemen. Microbial Drug Resistance. 24(10). 1537–1542.
6.
Rodríguez‐Baño, Jesús, Belén Gutiérrez‐Gutiérrez, Isabel Machuca, & Álvaro Pascual. (2018). Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. Clinical Microbiology Reviews. 31(2).
7.
Recacha, Esther, Jesús Machuca, Fernando Docobo-Pérez, et al.. (2018). Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy. 74(1). 66–73.
8.
López-Hernández, Inmaculada, Jesús Machuca, Paula Díaz de Alba, et al.. (2017). Molecular Characterization of Fluoroquinolone-Resistant Haemophilus parainfluenzae Clinical Isolates in Spain. Microbial Drug Resistance. 23(8). 935–939.
9.
Machuca, Jesús, Paula Díaz de Alba, Esther Recacha, Álvaro Pascual, & José Manuel Rodríguez-Martínez. (2017). Cytotoxic Effect Associated with Overexpression of QNR Proteins in Escherichia coli. Microbial Drug Resistance. 23(7). 822–825.
10.
Machuca, Jesús, et al.. (2016). Occurrence of the Plasmid-Mediated Fluoroquinolone Resistance qepA1 Gene in Two Clonal Clinical Isolates of CTX-M-15-Producing Escherichia coli from Algeria. Microbial Drug Resistance. 23(4). 497–499.
11.
Machuca, Jesús, et al.. (2016). Characterization of Plasmid-Mediated Quinolone Resistance Determinants in High-Level Quinolone-Resistant Enterobacteriaceae Isolates from the Community: First Report of qnrD Gene in Algeria. Microbial Drug Resistance. 23(1). 90–97.
12.
López‐Cerero, Lorena, et al.. (2015). Reduced Susceptibility to Cefepime in Clinical Isolates of Enterobacteriaceae Producing OXA-1 Beta-Lactamase. Microbial Drug Resistance. 22(2). 141–146.
13.
Machuca, Jesús, et al.. (2015). Comparison of clinical categories for Escherichia coli harboring specific qnr and chromosomal-mediated fluoroquinolone resistance determinants according to CLSI and EUCAST. Enfermedades Infecciosas y Microbiología Clínica. 34(3). 188–190.
14.
Fernández-Cuenca, Felipe, et al.. (2014). Description of the OXA-23 β-Lactamase Gene Located Within Tn 2007 in a Clinical Isolate of Acinetobacter baumannii from Spain. Microbial Drug Resistance. 21(2). 215–217.
15.
Cano, M.E., Eva Gato, José Garnacho‐Montero, et al.. (2014). Epidemiologic and Clinical Impact of Acinetobacter baumannii Colonization and Infection. Medicine. 93(5). 202–210.
16.
Jarque, Isidro, Javier López Jiménez, M. Jurado, et al.. (2013). Tratamiento de infecciones fúngicas en pacientes hematológicos de alto riesgo. La respuesta de AmBisome no se modifica con el uso previo de azoles de amplio espectro. Revista española de quimioterapia. Suplemento. 26(1). 64–69.
17.
López‐Cerero, Lorena, et al.. (2009). Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.. Clinical Microbiology and Infection. 16(2). 132–136.
18.
Rodríguez-Martínez, José Manuel, Laurent Poirel, Álvaro Pascual, & Patrice Nordmann. (2006). Plasmid-Mediated Quinolone Resistance in Australia. Microbial Drug Resistance. 12(2). 99–102.
19.
Williamson, Carolyn, Lynn Morris, Maureen F. Maughan, et al.. (2003). Characterization and Selection of HIV-1 Subtype C Isolates for Use in Vaccine Development. AIDS Research and Human Retroviruses. 19(2). 133–144.
20.
Pascual, Álvaro, et al.. (1990). Effect of Azithromycin, Roxithromycin and Erythromycin on Human Polymorphonuclear Leukocyte Function against <i>Staphylococcus aureus</i>. Chemotherapy. 36(6). 422–427.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Luis Martínez‐Martínez Breakdown of academic impact, for papers by Alkiviadis Vatopoulos Breakdown of academic impact, for papers by Patricia A. Bradford Breakdown of academic impact, for papers by Jesús Rodríguez‐Baño Breakdown of academic impact, for papers by Johann Pitout Breakdown of academic impact, for papers by Daniel F. Sahm Breakdown of academic impact, for papers by Ana Cristina Gales Breakdown of academic impact, for papers by B Olsson-Liljequist Breakdown of academic impact, for papers by Germán Bou Breakdown of academic impact, for papers by Anna-Pelagia Magiorakos